Sun Pharma on Saturday reported a 15% rise in third-quarter revenue to Rs 15,469 crore, while net profit rose 16% year-on-year to Rs 3,368 crore, driven by the growth of its branded businesses in India, emerging markets and global innovative medicines.“Our innovative product offering has been further expanded with the launch of Unloxcyt in the […]
